Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Anne, Fangberget"'
Autor:
Olav Engebraaten, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Bjørn Naume, Erik Wist, Steinar Lundgren, Anita Langerød, Vessela Kristensen, Hans Kristian Moen Vollan, Mette Nordberg Stokke, Elisabeth Wille, Ellen Schlitchting, Marit M. Holmen, Anne Fangberget, Helle Skjerven, Phuong Vu, Tone Olsen, Øystein Garred, Elin Borgen, Marit Krohn, Einar Rødland, Thomas Fleischer, Elen K. Møller, Hedda von der Lippe Gythfeldt, Silje Nord, Laxmi Silwal-Pandit
Table S1: Genes significantly differentially expressed in samples with pathological complete response compared to those without in the Combination arm. Table S2: DAVID analysis of 720 differentially expressed genes in tumors that achieved pathologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e901c0360fedf0b3dbd775cd8599e837
https://doi.org/10.1158/1078-0432.22463726.v1
https://doi.org/10.1158/1078-0432.22463726.v1
Autor:
Olav Engebraaten, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Bjørn Naume, Erik Wist, Steinar Lundgren, Anita Langerød, Vessela Kristensen, Hans Kristian Moen Vollan, Mette Nordberg Stokke, Elisabeth Wille, Ellen Schlitchting, Marit M. Holmen, Anne Fangberget, Helle Skjerven, Phuong Vu, Tone Olsen, Øystein Garred, Elin Borgen, Marit Krohn, Einar Rødland, Thomas Fleischer, Elen K. Møller, Hedda von der Lippe Gythfeldt, Silje Nord, Laxmi Silwal-Pandit
Purpose: Chemotherapy-induced alterations to gene expression are due to transcriptional reprogramming of tumor cells or subclonal adaptations to treatment. The effect on whole-transcriptome mRNA expression was investigated in a randomized phase II cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04364db62f867b10f35bf3f07192e044
https://doi.org/10.1158/1078-0432.c.6525497
https://doi.org/10.1158/1078-0432.c.6525497
Autor:
Olav Engebraaten, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Bjørn Naume, Erik Wist, Steinar Lundgren, Anita Langerød, Vessela Kristensen, Hans Kristian Moen Vollan, Mette Nordberg Stokke, Elisabeth Wille, Ellen Schlitchting, Marit M. Holmen, Anne Fangberget, Helle Skjerven, Phuong Vu, Tone Olsen, Øystein Garred, Elin Borgen, Marit Krohn, Einar Rødland, Thomas Fleischer, Elen K. Møller, Hedda von der Lippe Gythfeldt, Silje Nord, Laxmi Silwal-Pandit
Supplementary figures as referred to in the manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335948fcea3c98c55a831e458d84365c
https://doi.org/10.1158/1078-0432.22463729.v1
https://doi.org/10.1158/1078-0432.22463729.v1
Autor:
Dunia Hindosh, Ane Gerda Zahl Eriksson, Bodil Bjerkehagen, Ben Davidson, Anne Fangberget, Ida Marie Børresen, Frøydis Slettevoll, Lilach Kleinberg
Publikováno v:
Virchows Archiv. 479:419-424
Ectomesenchymoma is an exceedingly rare biphasic malignant tumor characterized by the presence of mesenchymal and neuroectodermal elements. The majority of patients are infants or children. We describe the first case of this entity diagnosed as a pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e997b52ba12c406b5b342e6b25f36bef
https://doi.org/10.1007/s00428-021-03057-x
https://doi.org/10.1007/s00428-021-03057-x
Autor:
Øystein Garred, Helle Skjerven, Silje Nord, Marit Muri Holmen, Bjørn Naume, Vessela N. Kristensen, Thomas Fleischer, Elin Borgen, Ole Christian Lingjærde, Laxmi Silwal-Pandit, Anne Lise Børresen-Dale, Ellen Schlichting, Olav Engebraaten, Steinar Lundgren, Anne Fangberget, Marit Krohn, Hedda von der Lippe Gythfelt, Erik Wist, Elen K. Møller
Publikováno v:
Cancer Research. 75:P4-11
The NeoAva study is a phase II clinical trial of patients with HER2 negative primary tumors of ≥25 mm treated with neoadjuvant chemotherapy (4 x FEC100 + 12 weeks of taxane-based therapy) and randomized (1:1) to receive bevacizumab or no bevacizuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::121963c694fc5bc27ab3fe762f969add
https://doi.org/10.1158/1538-7445.sabcs14-p4-11-14
https://doi.org/10.1158/1538-7445.sabcs14-p4-11-14
Autor:
Olav Engebraaten, Elin Borgen, Line Brennhaug Nilsen, Dag Rune Olsen, Therese Seierstad, Anne Fangberget, Oliver Geier
Publikováno v:
Journal of Magnetic Resonance Imaging. 40:1382-1391
Purpose To explore possible associations between in vivo pharmacokinetic dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters and the presence of disseminated tumor cells (DTCs) in bone marrow in breast cancer patients at the tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cbda43651180a769959669a0f2d3359
https://doi.org/10.1002/jmri.24502
https://doi.org/10.1002/jmri.24502
Autor:
I Stav, Erik Wist, Elin Borgen, Randi R. Mathiesen, Olav Engebråten, Cecilie Bendigtsen Schirmer, Bjørn Naume, Anna Barbro Sætersdal, MW Fagerland, Anne Fangberget
Publikováno v:
Cancer Research. 73:P1-08
Background: Results from studies with bevacizumab in addition to traditional neoadjuvant therapy (NAT) indicate a need for predictive biomarkers. As a sub-study of the NeoAva study (a neoadjuvant study), the aim was to investigate the potential assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e9f34af49a416dc8e2426f6557d4fdf
https://doi.org/10.1158/0008-5472.sabcs13-p1-08-21
https://doi.org/10.1158/0008-5472.sabcs13-p1-08-21
Autor:
Mads H. Haugen, Helle Kristine Skjerven, Evita M. Lindholm, Elin Borgen, Marit Muri Holmen, Øystein Garred, Anne-Lise Boerresen-Dale, Marit Krohn, Bjørn Naume, Gordon B. Mills, Olav Engebraaten, Ellen Schlichting, Ole Christian Lingjærde, Erik Wist, Laxmi Silwal-Pandit, Wei Zhao, Yiling Lu, Gunhild Mari Mælandsmo, Steinar Lundgren, Anne Fangberget
Publikováno v:
Cancer Research. 77:1813-1813
Antiangiogenic therapy using bevacizumab has proven effective for a number of cancers; however, in breast cancer there is an unmet need to identify patients that benefit from such treatment. Sampling of tumor biopsies before and during treatment, as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::734105bb23f55b1943d4f1d2bc6147fb
https://doi.org/10.1158/1538-7445.am2017-1813
https://doi.org/10.1158/1538-7445.am2017-1813
Autor:
Olav Engebraaten, Laxmi Silwal-Pandit, Thomas Fleischer, Elin Borgen, Øystein Garred, Anne Fangberget, Marit M Holmen, Ellen Schlichting, Helle Skjerven, Steinar Lundgren, Ingrid S Gribbestad, Marit Krohn, Hege Edvardsen, Vessela N Kristensen, Gordon Mills, Erik Wist, Anne-Lise Børresen-Dale
Publikováno v:
Cancer Research. 72:P5-17
Withdrawn by Author Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P5-17-02.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80606cddf9e5adbfc841fe2ae99f23da
https://doi.org/10.1158/0008-5472.sabcs12-p5-17-02
https://doi.org/10.1158/0008-5472.sabcs12-p5-17-02
Autor:
Marit Muri Holmen, Olav Engebraaten, Anne Fangberget, Knut Håkon Hole, Bjørn Naume, Dag Rune Olsen, Therese Seierstad, Hans-Jørgen Smith, Line Brennhaug Nilsen
Publikováno v:
European Radiology
Objective To explore the predictive value of MRI parameters and tumour characteristics before neoadjuvant chemotherapy (NAC) and to compare changes in tumour size and tumour apparent diffusion coefficient (ADC) during treatment, between patients who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa69721b0c43fabc2510ec6051c3a379
http://europepmc.org/articles/PMC3088808
http://europepmc.org/articles/PMC3088808